Product NDC: | 67253-700 |
Proprietary Name: | SELEGILINE HYDROCHLORIDE |
Non Proprietary Name: | SELEGILINE HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/1 & nbsp; SELEGILINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67253-700 |
Labeler Name: | DAVA International Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075352 |
Marketing Category: | ANDA |
Start Marketing Date: | 20061104 |
Package NDC: | 67253-700-06 |
Package Description: | 60 CAPSULE in 1 BOTTLE (67253-700-06) |
NDC Code | 67253-700-06 |
Proprietary Name | SELEGILINE HYDROCHLORIDE |
Package Description | 60 CAPSULE in 1 BOTTLE (67253-700-06) |
Product NDC | 67253-700 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SELEGILINE HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20061104 |
Marketing Category Name | ANDA |
Labeler Name | DAVA International Inc. |
Substance Name | SELEGILINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |